Scientists from Strand Life Sciences will demonstrate ‘Strand NGS’, an all-in-one next generation sequencing software at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) to be held from Oct 17 to 21 in Orlando, Florida.Strand is excited to be an exhibitor at ASHG 2017 and will use this opportunity to showcase the features of its flagship product, Strand NGS, which include: read alignment, analysis, data management, and its best-in-class visualization tools for next generation sequencing data.
Latest version of Strand NGS (v3.0) had seen many improvements with respect to speed, accuracy, and performance of its DNA-Seq workflow when compared to the BWA-GATK best practices workflow. This version also included one-shot pipeline execution, improved RNA-Seq performance, TSS plots and full support for HGVS notations for SNP effect analysis.
Strand NGS also added considerable value to Strand’s stack of artificial intelligence (AI)-powered bioinformatics and text mining platforms, called ‘Ramanujan’, aptly named after two great intellectuals of Indian origin (S. Ramanujan (1887-1920) and A.K. Ramanujan (1929-1993). Strand NGS along with the variant interpretation platform StrandOmics span next-generation genomics data analysis, clinical variant interpretation and reporting. With Ramanujan, Strand has enabled clinicians to integrate phenotype information with all other clinical reporting for more effective application in monitoring and screening of disease progression and recurrence.
Strand NGS is developed on award winning platform ‘Avadis’ which is being used by researchers across the globe from academic institutes, clinical labs, and pharmaceutical companies. Strand NGS offers total licensing flexibility ranging from a single user desktop version to an enterprise version (Server Edition) that enables very efficient data analysis, data sharing, and collaboration across many teams. At ASHG 2017, Strand will also present eight posters in the sessions on ‘Cancer’, ‘Bioinformatics and Computational Approaches’ and ‘Cardiovascular Phenotypes’. These posters will highlight the strengths of the tool by using case studies performed at Strand. A schedule of these poster sessions is available on the Strand NGS website.
About Strand NGS:
Strand NGS (formerly Avadis NGS) is an integrated next-generation sequencing data analysis software that supports extensive workflows for read alignment, DNA-Seq, RNA-Seq, small RNA-Seq, Methyl-Seq, MeDIP-Seq, and ChIP-Seq experiments. Strand will showcase new features in Strand NGS such as the enhanced speed and accuracy of SNP calling, UMI support for DNA, RNA and small RNA-Seq data, one-shot pipelines, multi-omic analysis, and the best-in-class visualizations that the tool offers. To know more, visit www.strand-ngs.com
Strand Life Sciences is a premier life science informatics innovation company. Founded in 2000, Strand is a leader in technology innovations for healthcare using genomics. By enhancing sequence-based diagnostics and clinical genomic data interpretation using a strong foundation of computational, scientific, and medical expertise, Strand is bringing individualized medicine to the world. To know more, visit www.strandls.com
Source: ASHG 2017